surgeries were performed in the national treatment center. Two patients underwent proton-beam radiation treatment.
The Spetzler and Martin 33 grading system was used to classify the AVMs. We adopted a classification of the Spetzler-Martin Grade 3 that was proposed by de Oliveira and coworkers 5 to facilitate grouping of cases, based on treatment modalities. Malformations in cortical areas classified as Grade 3 because of size were denoted as Grade 3a, whereas smaller AVMs classified as Grade 3 because of their critical location in central areas were denoted as Grade 3b. Based on our protocol, small, critically located Grade 3 lesions (Grade 3b) were most frequently treated using GKS, whereas patients with larger pial Grade 3 lesions (Grade 3a) underwent operation with or without preoperative embolization. Most Grade 4 AVMs were primarily treated with embolization followed by surgery or focused radiation. Most patients with Grade 5 AVMs declined therapy.
All patients treated throughout this period were seen by the same team of neurovascular surgeons and neuroradiologists.
The results of treatment were evaluated angiographically in terms of nidus occlusion and clinically by using the GOS.
14 Therapy was considered unsuccessful if flow through the fistula could be seen on angiograms 2 years after treatment. In cases treated using more than one therapeutic modality, the angiographically documented end point was set at 2 years after the final treatment was given. The patients' clinical conditions were assessed 12 months after treatment.
Results
In this regional population of 986,000 people cerebral AVMs were diagnosed de novo during an 11-year period (1989) (1990) (1991) (1992) (1993) (1994) (1995) (1996) (1997) (1998) (1999) in 135 patients, representing an incidence of 12.4 de novo diagnosed AVMs per 1,000,000 population per year. These cases were evenly distributed over the studied time span. The patients' clinical presentations were diverse (Table 1) , although hemorrhage was the initial manifestation of AVM in 69.6% (94 patients), giving a presentation incidence of 8.7 cases per 1,000,000 population per year. Epileptic seizures were the second most common presenting manifestation, whereas incidental findings of AVMs were rare.
An ICH was present in 83% of 94 patients presenting with hemorrhage. In 30 patients with small hematomas, the timing of AVM therapy was based on the angiographic findings, whereas in 48 patients harboring large (most often lobar) ICHs expedient surgical decompression was necessary. In 16 of these latter 48 patients with large ICHs suspected to have resulted from AVM rupture, their clinical condition allowed for the acquisition of preoperative angiography. In 13 patients transtentorial herniation was manifest on arrival in the neurosurgical center, and evacuation of the ICH was performed without preoperative angiography. In 19 mostly elderly patients with large lobar ICHs, the neurosurgeon on call at the time did not suspect an AVM as the source of bleeding, and surgery was performed without obtaining a preoperative angiogram. In total, 32 patients with large ICHs underwent surgery without undergoing preoperative angiography. In the majority of these 32 cases, the AVM revealed at surgery was small to medium sized and was extirpated in the same session. In four patients, large AVMs were found, and simple hematoma evacuation was performed. Only two of these four patients survived, both in poor condition, and follow-up angiography was not performed. Eighteen of the 32 patients who underwent surgery without undergoing preoperative angiography recovered, and in three of these an angiographically demonstrated AVM remnant received adjuvant treatment.
Coexistent arterial aneurysms were found in 19 patients; 11 of these presented with hemorrhage. Three patients suffered both ICH and SAH; eight patients suffered only SAH. In the entire series of 135 patients 27 suffered SAH and the 16 patients who did not harbor an arterial aneurysm all had coexistent ICH. Intraventricular hemorrhage occurred in 16 patients and was an isolated finding in seven of these.
The Spetzler-Martin classification was used to characterize 103 AVMs that were angiographically evaluated prior to therapy ( Table 2 ). Large high-grade AVMs were rare; Grade 1 to 3 lesions comprised 85% of the caseload. Frontal and temporal locations of the AVMs were most common, and 20 large AVMs involved more than one cortical region of the brain. There were 18 cases of cerebellar AVM, and brainstem and/or central structure involvement was present in 16 cases.
Seventeen percent of patients presented during the first two decades of life, and 20% presented in the seventh and eighth decades. Rupture of the AVM was predominate in children and adolescents (74%) and in patients older than 60 years of age (83%). Patients in their 30s and 40s had the lowest risk of bleeding (54%) when seizures and progressive deficits were most commonly observed. The male/female ratio was 1.33:1. For hemorrhage and seizure presentation the male/female ratio was 1.47 and 1.5, respectively, whereas for headache and progressive deficits the corresponding ratio was 0.6.
Primary therapy administered, selected according to our protocol, is shown in Table 3 , together with data for obliteration rates obtained after primary therapy and final oblit- eration rates obtained following adjuvant secondary treatments. Eighty-seven percent of patients with Grade 1 to 2 AVMs were treated with surgery; the remaining patients preferred to be treated with GKS. Patients with larger pial Grade 3 lesions (Grade 3a) underwent surgery with or without preoperative embolization, whereas most of those with small, critically located Grade 3 lesions (Grade 3b) were treated with GKS. Embolization was the first treatment performed for most patients with Grade 4 AVMs, followed by surgery or focused radiation therapy. In most patients with Grade 5 AVMs treatment was deterred. Using the present protocol, the final obliteration rate for Grade 1 to 3 AVMs, representing 85% of the overall caseload was 96%.
The overall management outcome in the 135 patients was classified as good according to the GOS (Score 5) in 61% of the cases, and the overall mortality rate was 9%. Based on population, 4.7 individuals per 1,000,000 population per year suffer death or permanent disability from cerebral AVMs. For patients with AVMs and hemorrhage, a good overall management outcome was obtained in only 48%. Parenchymal hemorrhage caused death and permanent morbidity in 59% of the cases.
In 35 patients harboring an unruptured Grade 1 to 3 AVM, a good management outcome was achieved in 96%.
Discussion
Only three other comparable population-based studies on cerebral AVMs are reported in the literature. 3, 13, 15 Numerous longitudinal studies offer insight into the natural history of the disease, but they do not provide definite data on the overall management perspective, and therapeutic needs because of the inevitable inclusion bias. 2, 4, 10, 21 Cerebral AVMs are rare lesions with 12.4 de novo diagnosed cases per 1,000,000 inhabitants per year in Sweden, a figure in close agreement with the findings in previous population-based series. It is clear from our unique epidemiological basis that this prospectively collected material represents every case of clinically manifest as well as incidentally discovered AVM in a population of 986,000 people during an 11-year period. Nonetheless, the calculated incidence most likely underestimates the true number of symptomatic AVMs. Many ICHs, especially those in elderly patients, are not studied angiographically or treated, and AVMs certainly account for some cases of sudden death. Autopsy records from this regional population were not reviewed in this study.
The patient age profile in our study is different from that of the Olmsted County study, 3 with more patients being in advanced decades of life. In Sweden, 18% of the population is older than the age 70 years, and treatment is never declined based on age alone. Our data demonstrate that elderly patients with AVMs present almost exclusively with hemorrhage and that AVMs are more commonly a cause of bleeding in this group of patients than is suggested by most researchers. [2] [3] [4] 10, 21 Each year, one elderly patient underwent surgery for an ICH, which proved at surgery to be caused by an AVM, suggesting that preoperative angiography in elderly persons with lobar ICHs should be performed more liberally. In pediatric patients, hemorrhage was the dominant form of presentation, whereas seizures and progressive deficits were mostly found in the intermediate-age groups. These observations on presenting symptoms are in agreement with observations from longitudinal natural history studies on cerebral AVMs.
Rupture of the AVM was the initial manifestation in 70% of all cases in this consecutive, nonselected series. These figures are higher than in all previously published series and draw attention to the relevance of bleeding from AVMs. Our findings contradict a recent study on morbidity among survivors of AVM rupture 12 but are supported by the findings of the population-based Olmsted County study. 3 In centers with population-based referral, AVM of the brain is predominantly a disease related to intracranial bleeding, and parenchymal clots have a profound impact on overall management outcome. In every seventh patient in whom an AVM has ruptured, transtentorial herniation from a hematoma became manifest within hours of ictus, and in 68% neurological deficits from hemorrhage were present prior to treatment.
The overall management result was classified as good (GOS Score 5) in 61% of all 135 patients included and in 49% of 94 patients presenting with hemorrhage. The overall mortality rate was 9%. This overall outcome of AVM management should be compared with the results of treatment for ruptured aneurysms. In our recent nationwide study of patients with 435 ruptured aneurysms, good overall management outcome was achieved in 56% of the cases, and the mortality rate was 21% 1 year after treatment. 30 Clearly, AVM rupture is as devastating as aneurysm rupture. Aneurysm ruptures are more lethal, whereas AVM rupture tends to result in more disability due to the high occurrence of lobar ICH. Despite the severity of AVM rupture, aneurysms, because of their relative frequency of occurrence, still cause six times as many poor results (26.8 cases/1,000,000 population/year 30 ) as AVMs (4.6 cases/ 1,000,000 population/year) from a population-based perspective. In rare patients with aneurysms and brainstem compression from large hematomas close to the sylvian or interhemispheric fissures, salvage surgery involving blind clipping without preoperative angiography can result in a remarkably good outcome. 1 In this series of patients with AVMs, salvage surgery for large lobar ICHs in 13 patients with manifest transtentorial herniation resulted in five deaths, seven poor recoveries, and only one good outcome.
In patients with unruptured AVMs, 77% were classified
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Population-based analysis of arteriovenous malformations 635 as Grade 1 to 2, and in this group, management outcome was good (GOS Score 5) in 98%; there were no deaths. The selection of treatment modalities for different AVM categories in this study is only one of many possible combinations. Primary GKS for surgically accessible, small cortical AVMs is a strong alternative in patients unwilling or unable to undergo surgery, although the obliteration rate at 2 years does not exceed 80%. 25, 35 During this 2-year period patients are exposed to an overall risk of bleeding comparable to the natural course of the disease. 8, 16 The final selection of a therapeutic method to be used in Grade 1 to 3 AVMs should also encompass evaluation of the risk of bleeding in individual cases, which may vary with the angioarchitectional characteristics of the malformation. 18, 26 Endovascular therapy for small surgically accessible lesions 38 as well as centrally located AVMs 23 is currently being explored. Several specialized centers have presented excellent results from the operative treatment of small, deep-seated AVMs, including those in the basal ganglia, thalamus, and brainstem. 32, 36 Many surgeons seem to prefer performing GKS in these critical locations, although GKS is not without complications. 7, 17, 29 For treatment of Grade 4 lesions, multimodality protocols, including various combinations of endovascular treatment, focused radiation treatment, and surgery, are currently on trial. 5, 6, 9, 11, 22, 28, 34, 37 Our data provide some interesting insights into actuarial population-based needs for different treatment modalities that can be applicable to centers with population-based referral. Table 4 shows the calculated number of procedures per 1,000,000 population per year for the present material and for two alternative treatment scenarios for Grade 1 to 3a AVMs. Emergency operation for ICHs comprise 4.4 operations per 1,000,000 population per year. Patients with Grade 4 AVMs are considered candidates for multimodality therapy and eventually 0.6 operations per 1,000,000 population per year were performed in this group. Patients with small deep-seated Grade 3b AVMs are candidates for GKS. Together, there were 1.9 procedures per 1,000,000 population per year in patients with AVMs of Grades 3b and 4. In patients with low-grade AVMs (1-3a) 4.8 nonemergency operations per 1,000,000 population per year were performed. Using our protocol, a total of 9.8 cases per 1,000,000 population per year were surgically treated, a figure in close agreement with the surgically oriented population-based study by Hernesniemi, et al. 13 It is of interest to analyze how alternative selections of therapeutic approaches to treat Grade 1 to 2 and pial Grade 3 AVMs in noncritical areas (Grade 3a) would have impacted the number of procedures performed per year on a population basis. Two possible scenarios, both focusing on tentative nonsurgical approaches to AVM treatment, can be considered. One option is to perform embolization for all Grade 1 to 3a AVMs as the primary method. The other option is to treat all AVMs smaller than 30 mm primarily by using GKS. In the embolization scenario, it is assumed that catheterization is technically possible in 90% of the cases, that the cure rate with nidus occlusion is 60% in Grade 1 to 2 and 20% in Grade 3 AVMs, that failed embolization is further treated using GKS with an 80% obliteration rate, and that failed GKS finally results in microsurgery. In the GKS scenario, it is assumed that the obliteration rate is 80% in AVMs smaller than 20 mm and 60% in AVMs 20 to 30 mm in diameter, that failed GKS results in embolization therapy with the above mentioned assumptions, and that failed obliteration finally results in microsurgery. It is further assumed that all patients with hematoma emergencies are surgically treated, and that those with small, critically located Grade 3 AVMs (Grade 3b) and Grade 4 AVMs are offered unchanged treatment.
In this attempt to quantify the need for different modalities in AVM treatment, based on a population of 1,000,000, figures for surgery range from six to 10 operations per year; those for embolization and GKS from two to seven per year, depending on the strategy at hand. With hypothetical nonsurgical approaches to Grade 1 to 3a lesions, the overall number of operations still amounts to six operations per 1,000,000 population per year because the need for emergency hematoma evacuation is the same regardless of treatment philosophy. With our surgically biased protocol, the final obliteration rate in patients with Grade 1 to 3a AVMs was 96%, with a procedure-related morbidity rate of 6% (Table 4) . With nonsurgical approaches to Grade 1 to 3a AVMs, the number of patients requiring treatment with more than one method for obliteration increases drastically. This is not convincingly superior to surgery in skilled hands. Each modality has its own complications, 7,9,11 and these become additive as procedures are added to the individual patient's protocol. Of greatest concern is the risk of bleeding or rebleeding after incomplete embolization or during the wait for obliteration after GKS in patients in whom the AVM is resectable. 8, 16, 25 In our series, 13 patients with Grade 1 to 3 AVMs were selected for GKS as a first choice therapy, with one fatal and one devastating bleed occurring at 6 and 9 months posttreatment, respectively.
Surgery is safe and the most efficient method for protecting a majority of patients with low-grade AVMs from the disastrous effects of rupture or rerupture. 19, 20, 24, [31] [32] [33] Such lesions in fact constitute as many as 85% of all AVMs seen in any institution with population-based referral. Surgery has also been shown to confer higher cost-effective- ness than GKS for small AVMs, provided that surgical morbidity and mortality rates are below 12% and 4%, respectively. 27 From a regional perspective, the scarcity of small, critically located Grade 3 or Grade 4 AVMs (1.6 cases/1,000,000 population/year) raises important questions, not only about how these malformations should be treated, but also about who should treat them.
